These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 2031394)

  • 21. [Malum perforans diabeticorum: treatment with controlled circulatory blockade and regional intravenous administration of antibiotics].
    Acevedo A; Decinti E; Toledo L; Pérez O
    Wien Med Wochenschr; 1993; 143(7-8):195-8. PubMed ID: 8379176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined primary subintimal and endoluminal angioplasty for ischaemic inferior-limb ulcers in diabetic patients: 5-year practice in a multidisciplinary 'diabetic-foot' service.
    Alexandrescu V; Hubermont G; Philips Y; Guillaumie B; Ngongang Ch; Coessens V; Vandenbossche P; Coulon M; Ledent G; Donnay JC
    Eur J Vasc Endovasc Surg; 2009 Apr; 37(4):448-56. PubMed ID: 19213580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pathogenesis of the formation of suppurative necrotic foot diseases in diabetes (review of the literature)].
    Georgadze AK; Gazetov BM
    Khirurgiia (Mosk); 1985 Aug; (8):141-7. PubMed ID: 3903323
    [No Abstract]   [Full Text] [Related]  

  • 24. Increased platelet activity in diabetic macroangiopathy.
    Diamantopoulos EJ; Raptis SA; Moulopoulos SD
    Horm Metab Res Suppl; 1992; 26():95-102. PubMed ID: 1490701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vascular evaluation and arterial reconstruction of the diabetic foot.
    Sumpio BE; Lee T; Blume PA
    Clin Podiatr Med Surg; 2003 Oct; 20(4):689-708. PubMed ID: 14636033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vasogen's immune modulation therapy (IMT) improves postischemic foot skin blood flow and transcutaneous pO(2) recovery rates in patients with advanced peripheral arterial occlusive disease.
    Edvinsson LI; Edvinsson ML; Angus Deveber G
    Int Angiol; 2003 Jun; 22(2):141-7. PubMed ID: 12865879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of pathogens in diabetic foot infection in South Indian type 2 diabetic patients.
    Viswanathan V; Jasmine JJ; Snehalatha C; Ramachandran A
    J Assoc Physicians India; 2002 Aug; 50():1013-6. PubMed ID: 12421021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcutaneous oxygen tension measurements on limbs of diabetic and nondiabetic patients with peripheral vascular disease.
    Wyss CR; Matsen FA; Simmons CW; Burgess EM
    Surgery; 1984 Mar; 95(3):339-46. PubMed ID: 6701790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Current management in the diagnosis and treatment of necrotic lesions of the diabetic foot].
    Bruni B; Bruni BK; Arolfo E; D'Adda A; Castellazzi R; Macario B; Fiorio E
    Ann Osp Maria Vittoria Torino; 1977; 20(1-6):21-42. PubMed ID: 616199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intra-arterial urokinase infusion in diabetic patients with rapidly progressive ischemic foot lesions.
    Vannini P; Ciavarella A; Mustacchio A; Rossi C
    Diabetes Care; 1991 Oct; 14(10):925-7. PubMed ID: 1773695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical experience with ofloxacin (DL-8280) in the therapy of various infections.
    Cristiano P; Iovene MR; Morelli G; Mandia L; Paradisi F; Altucci P
    J Chemother; 1989 Apr; 1(2):107-9. PubMed ID: 2732779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood flow in diabetics with foot lesions due to 'small vessel disease'.
    Irwin ST; Gilmore J; McGrann S; Hood J; Allen JA
    Br J Surg; 1988 Dec; 75(12):1201-6. PubMed ID: 3233470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Nuclear medicine studies of tissue concentration and hemodynamic effects of retrograde intravenous pressure infusions].
    Partsch H; Jochmann W; Mostbeck A; Hirschl M
    Wien Med Wochenschr; 1993; 143(7-8):172-6. PubMed ID: 8397459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of medial arterial calcification on O2 supply to exercising diabetic feet.
    Chantelau E; Ma XY; Herrnberger S; Dohmen C; Trappe P; Baba T
    Diabetes; 1990 Aug; 39(8):938-41. PubMed ID: 2373265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Venesection and subacute hemodilution in the treatment of ischemic complications of the foot in diabetics].
    L' Jarábek ; Abelovic M; Danková M
    Rozhl Chir; 1985 Jan; 64(1):34-42. PubMed ID: 3969589
    [No Abstract]   [Full Text] [Related]  

  • 36. The treatment of necrotic lesions in the diabetic patient.
    Rakow RB
    J Am Podiatry Assoc; 1967 Sep; 57(9):412-21. PubMed ID: 6073154
    [No Abstract]   [Full Text] [Related]  

  • 37. Level of plasma fibronectin in patients with peripheral vascular disease.
    Dionyssiou-Asteriou A; Karavassilis J
    Clin Chim Acta; 1985 Oct; 152(1-2):79-83. PubMed ID: 4053408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimicrobials in the '90s: expanded options for effective patient care. Proceedings of a symposium on ofloxacin. May 4-5, 1990.
    Urology; 1991; 37(3 Suppl):1-32. PubMed ID: 2003338
    [No Abstract]   [Full Text] [Related]  

  • 39. [Arterial calcinosis in the diabetic patient].
    de Haas WH
    J Radiol; 1979 Feb; 60(2):138. PubMed ID: 490464
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of macro- and microcirculatory functions on ceftriaxone concentrations in tissues of patients with stage IV peripheral arterial occlusive disease.
    Hirschl M; Kundi M; Hirschl AM; Georgopoulos A
    Antimicrob Agents Chemother; 1995 Jan; 39(1):15-9. PubMed ID: 7695297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.